evenue growth is likely to slow to 5–7 percent due to bottle availability issues, in sharp contrast to the 11% CAGR1the industry clocked over the last three fiscals. However, despite lower cash flows, a reduction in inventory will provide temporary relief to the working capital cycle for alcobev makers. This is as per a study of 31 alcobev makers (including 10 listed entities), which account for around 30 percent of the organised alcobev industry revenue of Rs 3.8 lakh crore, , said a release issued by CRISIL.evenue growth is likely to slow to 5–7 percent due to bottle availability issues, in sharp contrast to the 11% CAGR1the industry clocked over the last three fiscals. However, despite lower cash flows, a reduction in inventory will provide temporary relief to the working capital cycle for alcobev makers. This is as per a study of 31 alcobev makers (including 10 listed entities), which account for around 30 percent of the organised alcobev industry revenue of Rs 3.8 lakh crore, , said a release issued by CRISIL.
Pain in the pack to tear margin of alcobev makers 150-200 bps, said CRISIL
